was successfully added to your cart.

Your SEO optimized title page contents
Cannabis Consulting New York

New York is preparing to begin its medical marijuana program.  As the laws are just being finalized, anyone wanting to get into this 19 million person market must act now if they want to be chosen for a license.  New York will be awarding only five manufacturing licenses and 20 dispensary licenses for the first phase of the program.  The selection process will be incredibly competitive: to increase your odds of success hiring a consulting firm that is familiar with the ins and outs of the industry should be a top priority.  The Quantum 9 team has been behind many successful permitting and facility optimization projects, not only here in the States but also four other countries.  Whether you are just starting or have already been working on your plans, there is a lot to gain by engaging Quantum 9.  From proven, winning business plans to sustainability focused architectural and facility designs, to access to our world-class team and more. Applications for New York will be out soon, contact us today to get in front of the process and be that much closer to making your dreams a reality.

Below is our summary of the current New York State draft regulations to understand what will be required in your application submission.

New York State Draft Regulation Summary

Take a look at some of the key members in our consultant and business analyst team to understand why our services are the most sought after in the industry:

Ed Rosenthal – Master Level Gardner III/Most Published and Recognized Cannabis Author

Justin DeAngelis – Master Level Garner III/Head of Plant Nutrition

Derek Ogden – Security Consultant III

Michael Mayes – Quantum 9 CEO


[contact-form to=’kevin.mahoney@quantum9.net’ subject=’Cannabis Consulting New York Post Request’][contact-field label=’Name’ type=’name’ required=’1’/][contact-field label=’Email’ type=’email’ required=’1’/][contact-field label=’Phone’ type=’text’ required=’1’/][contact-field label=’Comment’ type=’textarea’ required=’1’/][/contact-form]

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply